Whitehawk Therapeutics, Inc. (WHWK)
4.05
-0.15
(-3.57%)
USD |
NASDAQ |
Sep 21, 16:00
4.05
0.00 (0.00%)
After-Hours: 20:00
Whitehawk Therapeutics Total Assets (Quarterly) : 193.99M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 193.99M |
| March 31, 2026 | 127.23M |
| December 31, 2025 | 150.94M |
| September 30, 2025 | 167.02M |
| June 30, 2025 | 180.82M |
| March 31, 2025 | 234.00M |
| December 31, 2024 | 70.71M |
| September 30, 2024 | 85.70M |
| June 30, 2024 | 101.62M |
| March 31, 2024 | 111.07M |
| December 31, 2023 | 132.42M |
| September 30, 2023 | 139.66M |
| June 30, 2023 | 151.23M |
| March 31, 2023 | 170.65M |
| December 31, 2022 | 184.24M |
| September 30, 2022 | 194.10M |
| June 30, 2022 | 128.64M |
| March 31, 2022 | 142.32M |
| December 31, 2021 | 157.91M |
| Date | Value |
|---|---|
| September 30, 2021 | 168.77M |
| June 30, 2021 | 37.42M |
| March 31, 2021 | 41.16M |
| December 31, 2020 | 18.82M |
| September 30, 2020 | 49.83M |
| June 30, 2020 | 45.72M |
| March 31, 2020 | 35.70M |
| December 31, 2019 | 39.94M |
| September 30, 2019 | 45.55M |
| June 30, 2019 | 49.60M |
| March 31, 2019 | 55.06M |
| December 31, 2018 | 64.12M |
| September 30, 2018 | 70.16M |
| June 30, 2018 | 69.54M |
| March 31, 2018 | 14.73M |
| December 31, 2017 | 21.03M |
| September 30, 2017 | 26.00M |
| June 30, 2017 | 29.79M |
| March 31, 2017 | 36.28M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.07M |
| Shareholders Equity (Quarterly) | 182.92M |
| Current Ratio | 17.38 |